NURIX THERAPEUTICS IN

Nurix Therapeutics to Participate in the 4th Annual Targeted Protein Degradation Summit

21 окт 2021 07:00:01 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

14 окт 2021 16:02:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders

30 сен 2021 07:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

13 июл 2021 16:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President, Product Development

21 июн 2021 16:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease

02 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its Board of Directors

01 июн 2021 16:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual Congress

21 май 2021 07:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Participate in Upcoming Investor Conferences

11 май 2021 07:00:01 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update

13 апр 2021 16:01:02 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

07 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Collaboration for the Discovery of Novel Drugs to Treat Pediatric Cancers

16 мар 2021 09:31:21 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Presentation of NX-1607 Preclinical Data at AACR

10 мар 2021 17:12:18 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

09 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics to Participate and Present at Upcoming Investor Conferences

09 мар 2021 07:30:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

04 мар 2021 20:01:29 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Launch of Proposed Public Offering of Common Stock

02 мар 2021 16:15:45 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update

16 фев 2021 16:01:00 Источник Nasdaq GlobeNewswire

Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies

07 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire